Sheldon Tobe
Sheldon Tobe
University of Toronto, Northern Ontario School of Medicine
Verified email at sunnybrook.ca
Title
Cited by
Cited by
Year
Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin
A Levin, CR Thompson, J Ethier, EJF Carlisle, S Tobe, D Mendelssohn, ...
American Journal of Kidney Diseases 34 (1), 125-134, 1999
11591999
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
HC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ...
The Lancet 394 (10193), 121-130, 2019
8692019
Guidelines for the management of chronic kidney disease
A Levin, B Hemmelgarn, B Culleton, S Tobe, P McFarlane, M Ruzicka, ...
Cmaj 179 (11), 1154-1162, 2008
5162008
Hypertension Canada's 2016 Canadian hypertension education program guidelines for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of …
AA Leung, K Nerenberg, SS Daskalopoulou, K McBrien, KB Zarnke, ...
Canadian Journal of Cardiology 32 (5), 569-588, 2016
4212016
Hypertension Canada’s 2018 guidelines for diagnosis, risk assessment, prevention, and treatment of hypertension in adults and children
KA Nerenberg, KB Zarnke, AA Leung, K Dasgupta, S Butalia, K McBrien, ...
Canadian Journal of Cardiology 34 (5), 506-525, 2018
4172018
The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension
SS Daskalopoulou, DM Rabi, KB Zarnke, K Dasgupta, K Nerenberg, ...
Canadian Journal of Cardiology 31 (5), 549-568, 2015
4082015
Seizures, sensorineural deafness, ataxia, mental retardation, and electrolyte imbalance (SeSAME syndrome) caused by mutations in KCNJ10
UI Scholl, M Choi, T Liu, VT Ramaekers, MG Häusler, J Grimmer, ...
Proceedings of the National Academy of Sciences 106 (14), 5842-5847, 2009
3882009
The 2014 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension
K Dasgupta, RR Quinn, KB Zarnke, DM Rabi, P Ravani, ...
Canadian Journal of Cardiology 30 (5), 485-501, 2014
3312014
Measurement of blood pressure in the office: recognizing the problem and proposing the solution
MG Myers, M Godwin, M Dawes, A Kiss, SW Tobe, J Kaczorowski
Hypertension 55 (2), 195-200, 2010
3272010
Cardiovascular disease in patients with chronic kidney disease: getting to the heart of the matter
A Levin, O Djurdjev, B Barrett, E Burgess, E Carlisle, J Ethier, K Jindal, ...
American Journal of kidney diseases 38 (6), 1398-1407, 2001
3062001
Conventional versus automated measurement of blood pressure in primary care patients with systolic hypertension: randomised parallel design controlled trial
MG Myers, M Godwin, M Dawes, A Kiss, SW Tobe, FC Grant, ...
Bmj 342, 2011
3022011
Hypertension Canada's 2017 guidelines for diagnosis, risk assessment, prevention, and treatment of hypertension in adults
AA Leung, SS Daskalopoulou, K Dasgupta, K McBrien, S Butalia, ...
Canadian Journal of Cardiology 33 (5), 557-576, 2017
2942017
The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2–therapy
DG Hackam, NA Khan, BR Hemmelgarn, SW Rabkin, RM Touyz, ...
Canadian Journal of Cardiology 26 (5), 249-258, 2010
2812010
The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension
DG Hackam, RR Quinn, P Ravani, DM Rabi, K Dasgupta, ...
Canadian Journal of Cardiology 29 (5), 528-542, 2013
2662013
The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part II–therapy
NA Khan, FA McAlister, SW Rabkin, R Padwal, RD Feldman, ...
Canadian Journal of Cardiology 22 (7), 583-593, 2006
2632006
The 2012 Canadian hypertension education program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy
SS Daskalopoulou, NA Khan, RR Quinn, M Ruzicka, DW McKay, ...
Canadian Journal of Cardiology 28 (3), 270-287, 2012
2432012
Canadian randomized trial of hemoglobin maintenance to prevent or delay left ventricular mass growth in patients with CKD
A Levin, O Djurdjev, C Thompson, B Barrett, J Ethier, E Carlisle, P Barre, ...
American journal of kidney diseases 46 (5), 799-811, 2005
2352005
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
HC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ...
The Lancet 394 (10193), 131-138, 2019
2262019
The effect of a reduction in alcohol consumption on blood pressure: a systematic review and meta-analysis
M Roerecke, J Kaczorowski, SW Tobe, G Gmel, OSM Hasan, J Rehm
The Lancet Public Health 2 (2), e108-e120, 2017
2112017
The endothelin antagonist atrasentan lowers residual albuminuria in patients with type 2 diabetic nephropathy
D De Zeeuw, B Coll, D Andress, JJ Brennan, H Tang, M Houser, ...
Journal of the American Society of Nephrology 25 (5), 1083-1093, 2014
2092014
The system can't perform the operation now. Try again later.
Articles 1–20